Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 9555787)

1.

Lipid lowering in a multidisciplinary clinic compared with primary physician management.

Harris DE, Record NB, Gipson GW, Pearson TA.

Am J Cardiol. 1998 Apr 1;81(7):929-33.

PMID:
9555787
2.

[Statins in primary prevention of coronary heart disease].

Paulweber B.

Wien Med Wochenschr. 1999;149(5-6):129-38. Review. German.

PMID:
10408004
3.

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

Vijan S, Hayward RA; American College of Physicians.

Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.

PMID:
15096337
4.

[Lipid lowering therapy for primary prevention of coronary heart disease--pro lipid lowering therapy].

Steinmetz A, Noll B, Maisch B, Schäfer JR.

Z Kardiol. 1998;87 Suppl 2:205-9. Review. German.

PMID:
9827484
5.
6.

Cholesterol: precursor to many lipid disorders.

Jones PH.

Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98. Review.

7.

Clinical context: current concepts of coronary heart disease management.

Jacobson TA.

Am J Med. 2001 Apr 16;110 Suppl 6A:3S-11S. Review.

PMID:
11311191
8.

A new reality: achieving cholesterol-lowering goals in clinical practice.

Gaw A.

Atheroscler Suppl. 2002 Apr;2(4):5-8; discussion 8-11. Review.

PMID:
11976071
9.

Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.

Lynn MM.

Adv Nurse Pract. 2000 Jun;8(6):36-41; quiz 42-3. Review. No abstract available.

PMID:
15658206
10.

Lipid management in a private cardiology practice (the Midwest Heart experience).

Brown AS, Cofer LA.

Am J Cardiol. 2000 Feb 10;85(3A):18A-22A. Review.

PMID:
10695703
11.

Hypercholesterolemia in children.

Shamir R, Lerner A, Fisher EA.

Isr Med Assoc J. 2000 Oct;2(10):767-71. Review. No abstract available.

12.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
13.

Are we aggressive enough in lowering cholesterol?

Waters DD.

Am J Cardiol. 2001 Aug 16;88(4A):10F-5F. Review.

PMID:
11520481
14.
15.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
16.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
17.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

18.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

19.

[Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared].

Kostner KM, Kostner GM.

Wien Klin Wochenschr. 1998 Oct 2;110(18):625-30. Review. German.

PMID:
9816634
20.

The role of lipid regulation in the prevention of coronary heart disease.

Bilheimer DW.

Eur Heart J. 1992 Jul;13 Suppl B:23-8. Review. No abstract available.

PMID:
1644098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk